Amino acid amides (AAA) were prepared and evaluated in seizure models. The AAA displayed moderate-to-excellent activity in the maximal electroshock seizure (MES) test and were devoid of activity in the subcutaneous Metrazol-induced (scMet) seizure test. The AAA anticonvulsant activity was neither strongly influenced by the C(2) substituent nor by the degree of terminal amine substitution. An in vitro
制备了
氨基酸酰胺(AAA)并在癫痫发作模型中进行了评估。AAA在最大的电击惊厥(
MES)测试中显示中等至优秀的活性,而在皮下美曲唑诱发的(scMet)惊厥测试中则没有活性。AAA抗惊厥活性既不受C(2)取代基,也不受末端胺取代度的强烈影响。一项体外代谢研究表明,结构-活性关系模式部分归因于在N末端胺单元发生的代谢过程。